VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,187,000 | +92.7% | 6,652 | +139.7% | 0.49% | +111.7% |
| Q2 2015 | $616,000 | +11.8% | 2,775 | 0.0% | 0.23% | +13.9% |
| Q1 2015 | $551,000 | +38.8% | 2,775 | 0.0% | 0.20% | +36.5% |
| Q4 2014 | $397,000 | +6.1% | 2,775 | -2.6% | 0.15% | +5.0% |
| Q3 2014 | $374,000 | -4.3% | 2,850 | -8.1% | 0.14% | -7.8% |
| Q2 2014 | $391,000 | -99.9% | 3,100 | -8.6% | 0.15% | -19.0% |
| Q1 2014 | $446,904,000 | +39240.1% | 3,390 | -65.0% | 0.19% | -60.5% |
| Q4 2013 | $1,136,000 | – | 9,675 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |